The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Drug-Induced Nephrotoxicity and Its Biomarkers
Open accessAbstract
Nephrotoxicity occurs when kidney-specific detoxification and excretion do not work properly due to the damage or destruction of kidney function by exogenous or endogenous toxicants. Exposure to drugs often results in toxicity in kidney which represents the major control system maintaining homeostasis of body and thus is especially susceptible to xenobiotics. Understanding the toxic mechanisms for nephrotoxicity provides useful information on the development of drugs with therapeutic benefi ts with reduced side effects. Mechanisms for drug-induced nephrotoxicity include changes in glomerular hemodynamics, tubular cell toxicity, inflammation, crystal nephropathy, rhabdomyolysis, and thrombotic microangiopathy. Biomarkers have been identifi ed for the assessment of nephrotoxicity. The discovery and development of novel biomarkers that can diagnose kidney damage earlier and more accurately are needed for effective prevention of drug-induced nephrotoxicity. Although some of them fail to confer specificity and sensitivity, several promising candidates of biomarkers were recently proved for assessment of nephrotoxicity. In this review, we summarize mechanisms of drug-induced nephrotoxicity and present the list of drugs that cause nephrotoxicity and biomarkers that can be used for early assessment of nephrotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ichimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L., & Sanicola, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4135 · Cited by 1,265
Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.
Huerta-Alardin, A. L., Varón, J., & Marik, P. E. (2004) · Critical Care · doi:10.1186/cc2978 · Cited by 1,078
Oldberg, A., Franzén, A., & Heinegård, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8819 · Cited by 1,078
Biomarkers of Acute Kidney Injury
Vaidya, V. S., Ferguson, M. A., & Bonventre, J. V. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094615 · Cited by 729
Vaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A., & Bonventre, J. V. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00291.2005 · Cited by 656
Next-generation biomarkers for detecting kidney toxicity
Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P., & Dieterle, F. (2010) · Nature Biotechnology · doi:10.1038/nbt0510-436 · Cited by 538
Nomura, S., Wills, A., Edwards, D., Heath, J., & Hogan, B. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.2.441 · Cited by 514
Drug-induced acute interstitial nephritis
Rossert, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002804.x · Cited by 488
Perneger, T. V., Whelton, P. K., & Klag, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312502 · Cited by 484 · cited 1×
“Chronic interstitial nephritis occurs frequently by long-term use of calcineurin inhibitors, lithium, some anticancer drugs or analgesics (Perneger et al., 1994; Fored et al., 2001; Isnard Bagnis, et al., 2004; Rodriguez-Iturbe and Garcia Garcia, 2010).”
BackgroundNielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M., & Kjeldsen, L. (1996) · Gut · doi:10.1136/gut.38.3.414 · Cited by 421
The Interferons: Mechanisms of Action and Clinical Applications
Baron, S. (1991) · JAMA · doi:10.1001/jama.1991.03470100067035 · Cited by 392
Shiraga, H., Min, W., VanDusen, W. J., Clayman, M. D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., & Neilson, E. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.426 · Cited by 390
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Schoolwerth, A. C., Sica, D. A., Ballermann, B. J., & Wilcox, C. S. (2001) · Circulation · doi:10.1161/hc4101.096153 · Cited by 363
Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration
Bailly, V., Zhang, Z., Meier, W., Cate, R., Sanicola, M., & Bonventre, J. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200562200 · Cited by 355
Drug-induced nephrotoxicity: concluded
(1984) · Reactions · doi:10.1007/bf03273412 · Cited by 339
Renal Dysfunction Complicating the Treatment of Hypertension
Palmer, B. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020676 · Cited by 326
Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kozak, C. A., Mock, B. A., & Morse, H. C. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.1.145 · Cited by 322
Crystal-induced acute renal failure
Perazella, M. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00041-8 · Cited by 322
Biomarkers of nephrotoxic acute kidney injury
Ferguson, M. A., Vaidya, V. S., & Bonventre, J. V. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.024 · Cited by 322
Drug-induced acute kidney injury
Schetz, M., Dasta, J., Goldstein, S., & Golper, T. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000184300.68383.95 · Cited by 313
Acetaminophen, Aspirin, and Chronic Renal Failure
Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C.-G., Blot, W. J., McLaughlin, J. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010323 · Cited by 292
Prognostic Value of Tubular Proteinuria and Enzymuria in Nonoliguric Acute Tubular Necrosis
Herget-Rosenthal, S., Poppen, D., Hüsing, J., Marggraf, G., Pietruck, F., Jakob, H.-G., Philipp, T., & Kribben, A. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027763 · Cited by 283
Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M., & Vanherweghem, J. L. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.009 · Cited by 244
Borregaard, N., Sehested, M., Nielsen, B., Sengelov, H., & Kjeldsen, L. (1995) · Blood · doi:10.1182/blood.v85.3.812.bloodjournal853812 · Cited by 227
Mogensen, C. E. (1971) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517109090668 · Cited by 221
Urinary cystatin C as a specific marker of tubular dysfunction
Conti, M., Moutereau, S., Zater, M., Lallali, K., Durrbach, A., Manivet, P., Eschwège, P., & Loric, S. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.050 · Cited by 208
Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O., Weiler, T., Rush, D., & Nickerson, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00766.x · Cited by 203
Treatment-related acute renal failure in the elderly: a hospital-based prospective study
Kohli, H. S., Bhaskaran, M. C., Muthukumar, T., Thennarasu, K., Sud, K., Jha, V., Gupta, K. L., & Sakhuja, V. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.2.212 · Cited by 187
Drug-induced renal failure: a focus on tubulointerstitial disease
Markowitz, G. S., & Perazella, M. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.005 · Cited by 185
Hohenegger, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.04.002 · Cited by 172
Urinary Albumin Excretion in Early and Long-Term Juvenile Diabetes
Mogensen, C. E. (1971) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517109086899 · Cited by 165
The Role of Tubulointerstitial Inflammation in the Progression of Chronic Renal Failure
Rodríguez‐Iturbe, B., & García-García, G. (2010) · Nephron Clinical Practice · doi:10.1159/000314656 · Cited by 157
Xu, S., Pauksen, K., & Venge, P. (1995) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519509089604 · Cited by 149
Drug-Induced Thrombotic Microangiopathy: Incidence, Prevention and Management
Pisoni, R., Ruggenenti, P. L., & Remuzzi, G. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00002 · Cited by 140
Rached, E., Hoffmann, D., Blumbach, K., Weber, K., Dekant, W., & Mally, A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn040 · Cited by 135
Bonventre, J. V., & Yang, L. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834008d3 · Cited by 132
Coco, T. J., & Klasner, A. E. (2004) · Current Opinion in Pediatrics · doi:10.1097/00008480-200404000-00017 · Cited by 119
Detection of urinary interleukin-8 in glomerular diseases
Wada, T., Yokoyama, H., Tomosugi, N., Hisada, Y., Ohta, S., Naito, T., Kobayashi, K., Mukaida, N., & Matsushima, K. (1994) · Kidney International · doi:10.1038/ki.1994.293 · Cited by 117
Shao, C., Li, M., Li, X., Wei, L., Zhu, L., Yang, F., Jia, L., Mu, Y., Wang, J., Guo, Z., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010975 · Cited by 114
Immunosuppressant-Induced Nephropathy
Olyaei, A. J., de Mattos, A. M., & Bennett, W. M. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00004 · Cited by 106
Ohlsson, S., Wieslander, J., & Segelmark, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02083.x · Cited by 78
Mauri, T., Bombino, M., Bertoli, E., Doni, A., Mantovani, A., & Pesenti, A. M. (2005) · Critical Care · doi:10.1186/cc3221 · Cited by 70
Transferrin Synthesis Is Increased in Nephrotic Patients Insufficiently to Replace Urinary Losses
Prinsen, B. H. C. M. T., der Velden, M. G. M. D. S., Kaysen, G. A., Straver, H. W., van Rijn, H. J. M., Stellaard, F., Berger, R., & Rabelink, T. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251017 · Cited by 70
Wu, Y., Yang, L., Su, T., Wang, C., Liu, G., & Li, X.-M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02370310 · Cited by 69
Kharasch, E. D., Schroeder, J. L., Bammler, T. K., Beyer, R., & Srinouanprachanh, S. L. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfj088 · Cited by 68
Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs
Nagai, J., & Takano, M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.497140 · Cited by 47
Urinary biomarkers and nephrotoxicity
Finn, W. F., & Porter, G. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-84843-3_6 · Cited by 37
Can acute renal failure be prevented?
Galley, H. F. (2000) · PubMed · Cited by 36
Cited by
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Toxicity of carbon tetrachloride, free radicals and role of antioxidants
Unsal, V., Cicek, M., & Sabancilar, İ. (2021) · Reviews on Environmental Health · doi:10.1515/reveh-2020-0048 · Cited by 320
Tanase, D. M., Gosav, E. M., Radu, S., Costea, C. F., Ciocoiu, M., Carauleanu, A., Lacatusu, C. M., Maranduca, M. A., Floria, M., & Rezus, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205238 · Cited by 191
Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights
Raza, Z., & Naureen, Z. (2020) · Nefrología · doi:10.1016/j.nefro.2019.06.009 · Cited by 43
Mobeen, A., Zulfiqar, A., Jari, A., Hafeez, A., Ali, H., & Imtiaz, Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2216777 · Cited by 1
Metadata
- Authors
- Kim, S.-Y., & Moon, A.-R.
- Venue
- Biomolecules and Therapeutics
- Published
- 2012-05-31
- Volume
- 20
- Issue
- 3
- Pages
- 268-272
- ISSN
- 1976-9148 (ISSN-L)
- OpenAlex
- W2039107480
- Cited by
- 287
- References
- 49
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.